Clinical Trials in Salt Lake City

Showing 4721-4740 of 16,694 trials

A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

NCT02476916

Study AG348-C-003 is a multicenter study designed to evaluate the safety and efficacy of different dose levels of AG-348 (mitapivat) in participants with PK deficiency.

Pyruvate Kinase Deficiency

Agios Pharmaceuticals, Inc.52 participantsStarted Jun 2015

Palo Alto, California, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +10 more locations

COMPLETEDPhase 2< 1 mile

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

NCT00447980

The purpose of this study is to look at the safety and effectiveness of CNTF implants on vision in persons with retinitis pigmentosa, Usher type II \& III, and Choroideremia. This research is being done because there are no effective therapies for people with these retinal degenerations. They are genetic disorders that affect one's ability to see at night, and later cause tunnel vision and loss of central vision. Retinal degenerations affect the retina, a light sensitive layer of cells in the back of the eye. Slowly over time, these cells die and cause permanent loss of vision. The implant is a small capsule that contains human retinal pigment epithelium cells. These cells have been given the ability to make CNTF and release it through the capsule membrane into the surrounding fluid. In this study, two different CNTF dose levels will be used: a high dose and a low dose in one eye, as well as a sham (or placebo) surgery in the other eye.

Retinitis Pigmentosa

Neurotech Pharmaceuticals73 participantsStarted Jan 2007

Beverly Hills, California, United States • Sacramento, California, United States • San Francisco, California, United States +9 more locations

A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

Find Trials by Condition in Salt Lake City

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Study of AGEN1571 in Participants With Advanced Solid Tumors

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

AltaValve Pivotal Trial

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

APX005M and Doxorubicin in Advanced Sarcoma

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma